RELPAX vs REPOTRECTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RELPAX vs REPOTRECTINIB: Safety Overview
| Metric | RELPAX | REPOTRECTINIB |
|---|---|---|
| Total FAERS Reports | 135 | 187 |
| Deaths Reported | 1 | 27 |
| Death Rate | 0.7% | 14.4% |
| Hospitalizations | 11 | 48 |
| Average Patient Age | 47.4 yrs | 60.8 yrs |
| % Female Patients | N/A | 61.1% |
| FDA Approval Date | N/A | Jun 11, 2024 |
| Manufacturer | N/A | E.R. Squibb & Sons, L.L.C. |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |